Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Odonate Therapeutics reports Q2 EPS (58c), consensus (33c) » 08:43
07/27/21
07/27
08:43
07/27/21
08:43
ODT

Odonate Therapeutics

$3.50 /

-0.32 (-8.38%)

In March Odonate…

In March Odonate announced the discontinuation of development of tesetaxel and its intent to wind down tesetaxel-related operations. As of June 30, 2021, Odonate has transitioned all patients in tesetaxel studies to appropriate alternative therapies or facilitated continuation of treatment with tesetaxel under compassionate use programs where appropriate. As of June 30, Odonate had $110.1M in cash compared to $157.3M as of December 31, 2020. This decrease in cash resulted primarily from cash used in operating activities for the six months ended June 30 of $47.9M.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$3.50 /

-0.32 (-8.38%)

ODT Odonate Therapeutics
$3.50 /

-0.32 (-8.38%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$3.50 /

-0.32 (-8.38%)

  • 28
    Aug
ODT Odonate Therapeutics
$3.50 /

-0.32 (-8.38%)

Over a week ago
On The Fly
Fly Intel: After-Hours Movers » 18:28
07/19/21
07/19
18:28
07/19/21
18:28
CCK

Crown Holdings

$101.33 /

-2.47 (-2.38%)

, IBM

IBM

$138.13 /

-0.79 (-0.57%)

, AMRX

Amneal Pharmaceuticals

$4.32 /

+0.01 (+0.23%)

, ODT

Odonate Therapeutics

$3.48 /

+0.025 (+0.72%)

, RCUS

Arcus Biosciences

$29.59 /

+0.16 (+0.54%)

, SIRI

Sirius XM

$6.35 /

-0.03 (-0.47%)

, PPG

PPG

$165.52 /

-4.77 (-2.80%)

, STLD

Steel Dynamics

$58.06 /

-1.8 (-3.01%)

, ZION

Zions Bancorp

$47.69 /

-1.91 (-3.85%)

, JBHT

J.B. Hunt

$159.83 /

-5.205 (-3.15%)

, ARDX

Ardelyx

$7.70 /

+0.195 (+2.60%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$47.69 /

-1.91 (-3.85%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

SIRI Sirius XM
$6.35 /

-0.03 (-0.47%)

RCUS Arcus Biosciences
$29.59 /

+0.16 (+0.54%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

JBHT J.B. Hunt
$159.83 /

-5.205 (-3.15%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

CCK Crown Holdings
$101.33 /

-2.47 (-2.38%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

AMRX Amneal Pharmaceuticals
$4.32 /

+0.01 (+0.23%)

CCK Crown Holdings
$101.33 /

-2.47 (-2.38%)

05/28/21 RBC Capital
Crown Holdings price target raised to $150 from $140 at RBC Capital
05/26/21
Fly Intel: Top five analyst downgrades
05/25/21 BMO Capital
Crown Holdings downgraded to Market Perform from Outperform at BMO Capital
05/25/21 Citi
Canpack U.S. plant news a negative for Ball and Crown, says Citi
IBM IBM
$138.13 /

-0.79 (-0.57%)

07/16/21 BMO Capital
IBM price target raised to $155 from $150 at BMO Capital
07/12/21 Summit Insights
UiPath initiated with a Sell at Summit Insights
04/20/21 Credit Suisse
IBM price target raised to $165 from $160 at Credit Suisse
04/20/21 Stifel
IBM price target raised to $151 from $147 at Stifel
AMRX Amneal Pharmaceuticals
$4.32 /

+0.01 (+0.23%)

04/14/21 Guggenheim
Amneal Pharmaceuticals price target raised to $8 from $6.50 at Guggenheim
04/06/21 RBC Capital
Amneal Pharmaceuticals transferred with a Sector Perform at RBC Capital
03/19/21 Piper Sandler
Amneal Pharmaceuticals price target raised to $9 from $7 at Piper Sandler
03/08/21 Goldman Sachs
Amneal Pharmaceuticals upgraded to Buy from Sell at Goldman Sachs
ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
RCUS Arcus Biosciences
$29.59 /

+0.16 (+0.54%)

06/24/21 SVB Leerink
Arcus Biosciences price target raised to $63 from $53 at SVB Leerink
02/25/21 Barclays
Arcus Biosciences price target raised to $45 from $40 at Barclays
02/25/21 Mizuho
Arcus Biosciences price target raised to $43 from $40 at Mizuho
01/20/21 Citi
Arcus Biosciences price target raised to $51 from $32 at Citi
SIRI Sirius XM
$6.35 /

-0.03 (-0.47%)

05/27/21 Morgan Stanley
Sirius XM shares 'cheap,' Liberty Sirius XM 'really cheap,' says Morgan Stanley
02/03/21 Citi
Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi
01/28/21
Fly Intel: Top five analyst downgrades
01/28/21 Credit Suisse
Sirius XM downgraded to Neutral after rally at Credit Suisse
PPG PPG
$165.52 /

-4.77 (-2.80%)

07/01/21 Societe Generale
PPG price target raised to $192 from $168 at Societe Generale
05/21/21 Deutsche Bank
PPG price target raised to $205 from $190 at Deutsche Bank
05/14/21 RBC Capital
PPG price target raised to $193 from $180 at RBC Capital
05/11/21 Goldman Sachs
PPG price target raised to $192 from $187 at Goldman Sachs
STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
Steel Dynamics price target raised to $72 from $68 at Deutsche Bank
06/18/21 Deutsche Bank
Steel Dynamics price target raised to $68 from $57 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst initiations
ZION Zions Bancorp
$47.69 /

-1.91 (-3.85%)

07/06/21 Keefe Bruyette
Zions Bancorp assumed with a Market Perform at Keefe Bruyette
05/17/21
Fly Intel: Top five analyst downgrades
05/17/21 Baird
Zions Bancorp downgraded to Underperform from Neutral at Baird
04/20/21 Truist
Zions Bancorp price target raised to $70 from $65 at Truist
JBHT J.B. Hunt
$159.83 /

-5.205 (-3.15%)

07/14/21 Citi
J.B. Hunt price target raised to $205 from $197 at Citi
07/13/21 Wells Fargo
J.B. Hunt price target raised to $203 from $192 at Wells Fargo
06/28/21 Barclays
J.B. Hunt price target raised to $180 from $170 at Barclays
06/21/21 Stifel
J.B. Hunt resumed with a Hold at Stifel
ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

05/06/21 Piper Sandler
Ardelyx's Q1 'largely quiet,' even with PDUFA delay, says Piper Sandler
04/29/21 Piper Sandler
Piper Sandler keeps Ardelyx rating, price target in spite of PDUFA delay
03/22/21 Wedbush
Ardelyx started with Outperform at Wedbush on tenapanor disruptor potential
03/22/21 Wedbush
Ardelyx initiated with an Outperform at Wedbush
ZION Zions Bancorp
$47.69 /

-1.91 (-3.85%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

SIRI Sirius XM
$6.35 /

-0.03 (-0.47%)

RCUS Arcus Biosciences
$29.59 /

+0.16 (+0.54%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

JBHT J.B. Hunt
$159.83 /

-5.205 (-3.15%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

CCK Crown Holdings
$101.33 /

-2.47 (-2.38%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

AMRX Amneal Pharmaceuticals
$4.32 /

+0.01 (+0.23%)

  • 28
    Aug
STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

CCK Crown Holdings
$101.33 /

-2.47 (-2.38%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

SIRI Sirius XM
$6.35 /

-0.03 (-0.47%)

RCUS Arcus Biosciences
$29.59 /

+0.16 (+0.54%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

JBHT J.B. Hunt
$159.83 /

-5.205 (-3.15%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

CCK Crown Holdings
$101.33 /

-2.47 (-2.38%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

ZION Zions Bancorp
$47.69 /

-1.91 (-3.85%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

SIRI Sirius XM
$6.35 /

-0.03 (-0.47%)

RCUS Arcus Biosciences
$29.59 /

+0.16 (+0.54%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

JBHT J.B. Hunt
$159.83 /

-5.205 (-3.15%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

Hot Stocks
EcoR1 Capital reports 7.6% passive stake in Odonate Therapeutics » 17:34
07/19/21
07/19
17:34
07/19/21
17:34
ODT

Odonate Therapeutics

$3.48 /

+0.025 (+0.72%)

EcoR1 Capital disclosed a…

EcoR1 Capital disclosed a 7.6% stake in Odonate Therapeutics, which represents over 2.93M shares. The filing does not allow for activism.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

  • 28
    Aug
ODT Odonate Therapeutics
$3.48 /

+0.025 (+0.72%)

Hot Stocks
Ikarian Capital reports 5.2% passive stake in Odonate Therapeutics » 06:19
07/06/21
07/06
06:19
07/06/21
06:19
ODT

Odonate Therapeutics

$3.48 /

+0.115 (+3.42%)

After market close on…

After market close on Friday, Ikarian Capital disclosed a 5.2% stake in Odonate Therapeutics, which represents about 1.99M shares. The filing does not allow for activism. Shares of Odonate are up about 33% at $4.61 in early pre-market trading.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$3.48 /

+0.115 (+3.42%)

ODT Odonate Therapeutics
$3.48 /

+0.115 (+3.42%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$3.48 /

+0.115 (+3.42%)

  • 28
    Aug
ODT Odonate Therapeutics
$3.48 /

+0.115 (+3.42%)

Over a month ago
Earnings
Odonate Therapeutics reports Q1 EPS (90c), consensus (81c) » 08:32
05/14/21
05/14
08:32
05/14/21
08:32
ODT

Odonate Therapeutics

$3.00 /

+0.005 (+0.17%)

As of March 31, Odonate…

As of March 31, Odonate had $133.2M in cash compared to $157.3M as of December 31, 2020. This decrease in cash resulted primarily from cash used in operating activities for the three months ended March 31 of $24.9M. Odonate's net loss for the three months ended March 31, 2021 and 2020 was $33.8M and $30.2M, or 90c and 99c per share, respectively.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$3.00 /

+0.005 (+0.17%)

ODT Odonate Therapeutics
$3.00 /

+0.005 (+0.17%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$3.00 /

+0.005 (+0.17%)

  • 28
    Aug
ODT Odonate Therapeutics
$3.00 /

+0.005 (+0.17%)

Over a quarter ago
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:30
03/22/21
03/22
16:30
03/22/21
16:30
KSU

Kansas City Southern

$249.10 /

+25.04 (+11.18%)

, AZN

AstraZeneca

$51.21 /

+2.03 (+4.13%)

, AAPL

Apple

$123.38 /

+3.52 (+2.94%)

, AMZN

Amazon.com

$3,111.03 /

+37.04 (+1.20%)

, GOOG

Alphabet

$2,039.49 /

-3.43 (-0.17%)

, GOOGL

Alphabet Class A

$2,030.74 /

+2.81 (+0.14%)

, FB

Facebook

$293.53 /

+3.38 (+1.16%)

, STLA

Stellantis

$17.57 /

-0.08 (-0.45%)

, F

Ford

$12.87 /

+0.04 (+0.31%)

, APO

Apollo Global

$49.46 /

+2.23 (+4.72%)

, TBA

Thoma Bravo Advantage

$10.71 /

-0.12 (-1.11%)

, CPRX

Catalyst Pharmaceuticals

$4.68 /

+0.32 (+7.34%)

, BOX

Box

$23.63 /

+1.08 (+4.79%)

, ODT

Odonate Therapeutics

$3.95 /

-15.06 (-79.22%)

, RLX

RLX Technology

$10.14 /

-9.325 (-47.91%)

The major averages…

ShowHide Related Items >><<
TBA Thoma Bravo Advantage
$10.71 /

-0.12 (-1.11%)

STLA Stellantis
$17.57 /

-0.08 (-0.45%)

RLX RLX Technology
$10.14 /

-9.325 (-47.91%)

ODT Odonate Therapeutics
$3.95 /

-15.06 (-79.22%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

FB Facebook
$293.53 /

+3.38 (+1.16%)

F Ford
$12.87 /

+0.04 (+0.31%)

CPRX Catalyst Pharmaceuticals
$4.68 /

+0.32 (+7.34%)

BOX Box
$23.63 /

+1.08 (+4.79%)

AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

APO Apollo Global
$49.46 /

+2.23 (+4.72%)

AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

AAPL Apple
$123.38 /

+3.52 (+2.94%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
03/22/21 TD Securities
Canadian Pacific price target raised to C$585 from C$505 at TD Securities
03/22/21 Wells Fargo
Kansas City Southern price target raised to $275 from $257 at Wells Fargo
03/22/21 Wells Fargo
Canadian Pacific price target raised to $418 from $401 at Wells Fargo
AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Jefferies
AstraZeneca upgraded to Buy from Hold at Jefferies
03/09/21 Berenberg
AstraZeneca price target lowered to 9,500 GBp from 10,000 GBp at Berenberg
AAPL Apple
$123.38 /

+3.52 (+2.94%)

03/22/21 Wedbush
Apple iPhone checks show supercycle on track, says Wedbush
03/18/21 Rosenblatt
Lumentum downgraded to Neutral on Apple headwinds at Rosenblatt
03/17/21 JPMorgan
Apple chip transition an overhang on Qualcomm shares, says JPMorgan
03/16/21 Evercore ISI
Apple price target raised to $175 from $163 at Evercore ISI
AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

03/23/21 Piper Sandler
Piper remains buyer of telehealth companies despite Amazon competition
03/19/21 JPMorgan
JPMorgan positive on Amazon's 'deeper partnership' with NFL
03/18/21 RBC Capital
Concerns over Amazon's impact on Teladoc overdone, says RBC Capital
03/17/21 Credit Suisse
Amazon telehealth expansion was expected given prior reports, says Credit Suisse
GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
03/18/21 Alliance Global Partners
Alliance Global Partners reiterates Buy on LiveXLive Media, ups target to $10
03/11/21 Deutsche Bank
ADT upgraded to Buy on potential of Google solution at Deutsche Bank
03/10/21 Susquehanna
LiveRamp remains confident in go-to-market strategy, says Susquehanna
GOOGL Alphabet Class A
$2,030.74 /

+2.81 (+0.14%)

03/08/21 Oppenheimer
Too soon to tell impact of Chrome policy changes on e-commerce, says Oppenheimer
FB Facebook
$293.53 /

+3.38 (+1.16%)

03/08/21 Jefferies
Facebook looks attractive following pullback, says Jefferies
02/26/21 Jefferies
Twitter price target raised to $79 from $64 at Jefferies
02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
STLA Stellantis
$17.57 /

-0.08 (-0.45%)

03/23/21 Kepler Cheuvreux
Autos upgraded to Overweight from Neutral at Kepler Cheuvreux
03/15/21 JPMorgan
Stellantis price target raised to EUR 20 from EUR 18 at JPMorgan
03/15/21 Deutsche Bank
Stellantis initiated with a Buy at Deutsche Bank
03/02/21 AlphaValue
Stellantis upgraded to Buy from Add at AlphaValue
F Ford
$12.87 /

+0.04 (+0.31%)

03/19/21
Fly Intel: Top five analyst upgrades
03/19/21 Barclays
Ford upgraded to Overweight from Equal Weight at Barclays
03/19/21 Barclays
Ford upgraded to Overweight from Equal Weight at Barclays
03/03/21 Morgan Stanley
Mustang Mach-E took major Tesla EV share in February, says Morgan Stanley
APO Apollo Global
$49.46 /

+2.23 (+4.72%)

03/22/21 Citi
Apollo Global upgraded to Buy at Citi on 'favorable' governance changes
03/22/21 Citi
Apollo Global upgraded to Buy from Neutral at Citi
03/09/21 BMO Capital
Apollo Global price target raised to $70 from $58 at BMO Capital
03/09/21 JPMorgan
JPMorgan downgrades Apollo to Neutral after Athene acquisition
TBA Thoma Bravo Advantage
$10.71 /

-0.12 (-1.11%)

CPRX Catalyst Pharmaceuticals
$4.68 /

+0.32 (+7.34%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
BOX Box
$23.63 /

+1.08 (+4.79%)

03/23/21 DA Davidson
Box price target raised to $25 from $18 at DA Davidson
01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
ODT Odonate Therapeutics
$3.95 /

-15.06 (-79.22%)

03/22/21 Goldman Sachs
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs
03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
RLX RLX Technology
$10.14 /

-9.325 (-47.91%)

03/12/21 Citi
RLX Technology initiated with a Buy at Citi
ODT Odonate Therapeutics
$3.95 /

-15.06 (-79.22%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

GOOGL Alphabet Class A
$2,030.74 /

+2.81 (+0.14%)

GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

FB Facebook
$293.53 /

+3.38 (+1.16%)

F Ford
$12.87 /

+0.04 (+0.31%)

CPRX Catalyst Pharmaceuticals
$4.68 /

+0.32 (+7.34%)

BOX Box
$23.63 /

+1.08 (+4.79%)

AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

APO Apollo Global
$49.46 /

+2.23 (+4.72%)

AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

AAPL Apple
$123.38 /

+3.52 (+2.94%)

  • 22
    Jan
  • 28
    Aug
TBA Thoma Bravo Advantage
$10.71 /

-0.12 (-1.11%)

STLA Stellantis
$17.57 /

-0.08 (-0.45%)

RLX RLX Technology
$10.14 /

-9.325 (-47.91%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

GOOGL Alphabet Class A
$2,030.74 /

+2.81 (+0.14%)

GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

FB Facebook
$293.53 /

+3.38 (+1.16%)

F Ford
$12.87 /

+0.04 (+0.31%)

BOX Box
$23.63 /

+1.08 (+4.79%)

AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

APO Apollo Global
$49.46 /

+2.23 (+4.72%)

AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

AAPL Apple
$123.38 /

+3.52 (+2.94%)

TBA Thoma Bravo Advantage
$10.71 /

-0.12 (-1.11%)

STLA Stellantis
$17.57 /

-0.08 (-0.45%)

RLX RLX Technology
$10.14 /

-9.325 (-47.91%)

ODT Odonate Therapeutics
$3.95 /

-15.06 (-79.22%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

FB Facebook
$293.53 /

+3.38 (+1.16%)

F Ford
$12.87 /

+0.04 (+0.31%)

CPRX Catalyst Pharmaceuticals
$4.68 /

+0.32 (+7.34%)

BOX Box
$23.63 /

+1.08 (+4.79%)

AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

APO Apollo Global
$49.46 /

+2.23 (+4.72%)

AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

AAPL Apple
$123.38 /

+3.52 (+2.94%)

TBA Thoma Bravo Advantage
$10.71 /

-0.12 (-1.11%)

RLX RLX Technology
$10.14 /

-9.325 (-47.91%)

KSU Kansas City Southern
$249.10 /

+25.04 (+11.18%)

GOOGL Alphabet Class A
$2,030.74 /

+2.81 (+0.14%)

GOOG Alphabet
$2,039.49 /

-3.43 (-0.17%)

FB Facebook
$293.53 /

+3.38 (+1.16%)

F Ford
$12.87 /

+0.04 (+0.31%)

BOX Box
$23.63 /

+1.08 (+4.79%)

AZN AstraZeneca
$51.21 /

+2.03 (+4.13%)

APO Apollo Global
$49.46 /

+2.23 (+4.72%)

AMZN Amazon.com
$3,111.03 /

+37.04 (+1.20%)

AAPL Apple
$123.38 /

+3.52 (+2.94%)

Recommendations
Odonate Therapeutics price target lowered to $4 from $11 at Goldman Sachs » 13:17
03/22/21
03/22
13:17
03/22/21
13:17
ODT

Odonate Therapeutics

$4.00 /

-15.01 (-78.96%)

Goldman Sachs analyst…

Goldman Sachs analyst Paul Choi lowered the firm's price target on Odonate Therapeutics to $4 from $11 after the company announced that it will discontinue tesetaxel development and wind down operations based on the fact that tesetaxel is unlikely to gain FDA approval based on feedback from a pre-NDA meeting with the agency. Choi, who notes that he had considered tesetaxel's risk/benefit profile as poor and took a cautious view on its regulatory prospects given concern about its tolerability profile, keeps a Sell rating on Odonate shares.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$4.00 /

-15.01 (-78.96%)

ODT Odonate Therapeutics
$4.00 /

-15.01 (-78.96%)

03/22/21 Jefferies
Odonate Therapeutics downgraded to Hold from Buy at Jefferies
03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$4.00 /

-15.01 (-78.96%)

  • 28
    Aug
ODT Odonate Therapeutics
$4.00 /

-15.01 (-78.96%)

Downgrade
Odonate Therapeutics downgraded to Hold from Buy at Jefferies » 12:42
03/22/21
03/22
12:42
03/22/21
12:42
ODT

Odonate Therapeutics

$4.14 /

-14.87 (-78.22%)

Jefferies analyst Michael…

Jefferies analyst Michael Yee downgraded Odonate Therapeutics to Hold from Buy with a price target of $4, down from $45.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$4.14 /

-14.87 (-78.22%)

ODT Odonate Therapeutics
$4.14 /

-14.87 (-78.22%)

03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$4.14 /

-14.87 (-78.22%)

  • 28
    Aug
ODT Odonate Therapeutics
$4.14 /

-14.87 (-78.22%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:17
03/22/21
03/22
12:17
03/22/21
12:17
KSU

Kansas City Southern

$252.50 /

+28.44 (+12.69%)

, CP

Canadian Pacific

$365.60 /

-14.98 (-3.94%)

, AZN

AstraZeneca

$50.69 /

+1.51 (+3.07%)

, AAPL

Apple

$122.53 /

+2.67 (+2.23%)

, AMZN

Amazon.com

$3,110.34 /

+36.35 (+1.18%)

, GOOG

Alphabet

$2,041.69 /

-1.23 (-0.06%)

, GOOGL

Alphabet Class A

$2,030.27 /

+2.34 (+0.12%)

, FB

Facebook

$296.36 /

+6.21 (+2.14%)

, TBA

Thoma Bravo Advantage

$10.83 /

+ (+0.00%)

, CPRX

Catalyst Pharmaceuticals

$4.66 /

+0.3 (+6.88%)

, BOX

Box

$24.10 /

+1.55 (+6.87%)

, ODT

Odonate Therapeutics

$4.12 /

-14.89 (-78.33%)

, RLX

RLX Technology

$10.95 /

-8.515 (-43.75%)

The major averages are…

ShowHide Related Items >><<
TBA Thoma Bravo Advantage
$10.83 /

+ (+0.00%)

RLX RLX Technology
$10.95 /

-8.515 (-43.75%)

ODT Odonate Therapeutics
$4.12 /

-14.89 (-78.33%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

FB Facebook
$296.36 /

+6.21 (+2.14%)

CPRX Catalyst Pharmaceuticals
$4.66 /

+0.3 (+6.88%)

CP Canadian Pacific
$365.60 /

-14.98 (-3.94%)

BOX Box
$24.10 /

+1.55 (+6.87%)

AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

AAPL Apple
$122.53 /

+2.67 (+2.23%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

03/22/21 TD Securities
Canadian Pacific price target raised to C$585 from C$505 at TD Securities
03/22/21 Wells Fargo
Kansas City Southern price target raised to $275 from $257 at Wells Fargo
03/22/21 Wells Fargo
Canadian Pacific price target raised to $418 from $401 at Wells Fargo
03/22/21 Cowen
Cowen sees value creation in merger with Canadian Pacific and KSU
CP Canadian Pacific
$365.60 /

-14.98 (-3.94%)

03/22/21 CIBC
Canadian Pacific price target raised to C$560 from C$490 at CIBC
03/22/21 National Bank
Canadian Pacific price target raised to C$490 from C$445 at National Bank
03/22/21 Raymond James
Canadian Pacific price target raised to C$500 from C$485 at Raymond James
AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Jefferies
AstraZeneca upgraded to Buy from Hold at Jefferies
03/09/21 Berenberg
AstraZeneca price target lowered to 9,500 GBp from 10,000 GBp at Berenberg
AAPL Apple
$122.53 /

+2.67 (+2.23%)

03/22/21 Wedbush
Apple iPhone checks show supercycle on track, says Wedbush
03/18/21 Rosenblatt
Lumentum downgraded to Neutral on Apple headwinds at Rosenblatt
03/17/21 JPMorgan
Apple chip transition an overhang on Qualcomm shares, says JPMorgan
03/16/21 Evercore ISI
Apple price target raised to $175 from $163 at Evercore ISI
AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

03/19/21 JPMorgan
JPMorgan positive on Amazon's 'deeper partnership' with NFL
03/18/21 RBC Capital
Concerns over Amazon's impact on Teladoc overdone, says RBC Capital
03/17/21 Credit Suisse
Amazon telehealth expansion was expected given prior reports, says Credit Suisse
03/17/21 JPMorgan
Teladoc reaction to 'not unexpected' Amazon news 'overdone,' says JPMorgan
GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

03/18/21 Alliance Global Partners
Alliance Global Partners reiterates Buy on LiveXLive Media, ups target to $10
03/11/21 Deutsche Bank
ADT upgraded to Buy on potential of Google solution at Deutsche Bank
03/10/21 Susquehanna
LiveRamp remains confident in go-to-market strategy, says Susquehanna
03/08/21 Oppenheimer
Too soon to tell impact of Chrome policy changes on e-commerce, says Oppenheimer
GOOGL Alphabet Class A
$2,030.27 /

+2.34 (+0.12%)

03/08/21 KeyBanc
Trade Desk upgraded to Overweight from Sector Weight at KeyBanc
FB Facebook
$296.36 /

+6.21 (+2.14%)

03/08/21 Jefferies
Facebook looks attractive following pullback, says Jefferies
02/26/21 Jefferies
Twitter price target raised to $79 from $64 at Jefferies
02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
TBA Thoma Bravo Advantage
$10.83 /

+ (+0.00%)

CPRX Catalyst Pharmaceuticals
$4.66 /

+0.3 (+6.88%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
BOX Box
$24.10 /

+1.55 (+6.87%)

01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
08/27/20 Craig-Hallum
Box price target raised to $30 from $24 at Craig-Hallum
08/27/20 Morgan Stanley
Box has large, attractive market opportunity, says Morgan Stanley
ODT Odonate Therapeutics
$4.12 /

-14.89 (-78.33%)

03/22/21 Cowen
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen
08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
RLX RLX Technology
$10.95 /

-8.515 (-43.75%)

03/12/21 Citi
RLX Technology initiated with a Buy at Citi
ODT Odonate Therapeutics
$4.12 /

-14.89 (-78.33%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

GOOGL Alphabet Class A
$2,030.27 /

+2.34 (+0.12%)

GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

FB Facebook
$296.36 /

+6.21 (+2.14%)

CPRX Catalyst Pharmaceuticals
$4.66 /

+0.3 (+6.88%)

CP Canadian Pacific
$365.60 /

-14.98 (-3.94%)

BOX Box
$24.10 /

+1.55 (+6.87%)

AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

AAPL Apple
$122.53 /

+2.67 (+2.23%)

  • 22
    Jan
  • 28
    Aug
TBA Thoma Bravo Advantage
$10.83 /

+ (+0.00%)

RLX RLX Technology
$10.95 /

-8.515 (-43.75%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

FB Facebook
$296.36 /

+6.21 (+2.14%)

BOX Box
$24.10 /

+1.55 (+6.87%)

AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

AAPL Apple
$122.53 /

+2.67 (+2.23%)

TBA Thoma Bravo Advantage
$10.83 /

+ (+0.00%)

RLX RLX Technology
$10.95 /

-8.515 (-43.75%)

ODT Odonate Therapeutics
$4.12 /

-14.89 (-78.33%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

FB Facebook
$296.36 /

+6.21 (+2.14%)

CPRX Catalyst Pharmaceuticals
$4.66 /

+0.3 (+6.88%)

BOX Box
$24.10 /

+1.55 (+6.87%)

AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

AAPL Apple
$122.53 /

+2.67 (+2.23%)

TBA Thoma Bravo Advantage
$10.83 /

+ (+0.00%)

RLX RLX Technology
$10.95 /

-8.515 (-43.75%)

KSU Kansas City Southern
$252.50 /

+28.44 (+12.69%)

GOOGL Alphabet Class A
$2,030.27 /

+2.34 (+0.12%)

GOOG Alphabet
$2,041.69 /

-1.23 (-0.06%)

FB Facebook
$296.36 /

+6.21 (+2.14%)

BOX Box
$24.10 /

+1.55 (+6.87%)

AZN AstraZeneca
$50.69 /

+1.51 (+3.07%)

AMZN Amazon.com
$3,110.34 /

+36.35 (+1.18%)

AAPL Apple
$122.53 /

+2.67 (+2.23%)

Downgrade
Odonate Therapeutics downgraded to Market Perform from Outperform at Cowen » 11:33
03/22/21
03/22
11:33
03/22/21
11:33
ODT

Odonate Therapeutics

$4.53 /

-14.48 (-76.17%)

Cowen analyst Marc Frahm…

Cowen analyst Marc Frahm downgraded Odonate Therapeutics to Market Perform from Outperform.

ShowHide Related Items >><<
ODT Odonate Therapeutics
$4.53 /

-14.48 (-76.17%)

ODT Odonate Therapeutics
$4.53 /

-14.48 (-76.17%)

08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
ODT Odonate Therapeutics
$4.53 /

-14.48 (-76.17%)

  • 28
    Aug
ODT Odonate Therapeutics
$4.53 /

-14.48 (-76.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.